Recombinant DNA Advisory Committee - 12/1-2/94 
Philip Noguchi, Food and Drug Administration 
Rachel Nowak, Science Magazine 
Carol Ohmstede, Burroughs Wellcome 
Hideho Okada, Nagoya University 
Sheryl Osbourne, Viagene, Inc. 
Jeffrey Ostrove, Microbiological Associates, Inc. 
Ed Otto, Genetic Therapy, Inc. 
Keiya Ozawa, Jichi Medical School 
Guy Page, Promega Corporation 
John Park, University of California, San Francisco 
Virginia Parks, Act-up Goldengate 
Amy Patterson, Food and Drug Administration 
Nick Pelliccione, Schering-Plough Corporation 
Michael Pensiero, Genetic Therapy, Inc. 
Stephen Pijar, University of Maryland 
Charles Prussak, University of California, San Diego 
Raj Puri, Food and Drug Administration 
Abdur Razzaque, Food and Drug Administration 
Gene Resnick, Schering-Plough Corporation 
Rex Rhein, Biotechnology Newswatch 
Dwaine Rieves, Food and Drug Administration 
Joseph Rokovich, Somatix Therapy Corporation 
Gene Rosenthal, Public 
Jack Roth, MD Anderson Cancer Center 
Michael Roy, Agracetus, Inc 
Patricia Ryan, Genetic Therapy, Inc 
Alain Schreiber, Vical, Inc 
G. Terry Sharrer, Smithsonian Institution 
Tomiko Shimada, Ambiance Awareness International, Inc. 
H. David Shine, Baylor College of Medicine 
Helen Shu, Systemix Corporation 
Judith St. George, Genzyme Corporation 
Peter Stambrook, University of Cincinnati 
Margi Stuart, Breast Cancer Action 
Franck Sturtz, Progenitor, Inc 
Nevin Summers, Ingenex, Inc 
Yoshiyuki Takahara, Ajinomoto Company 
Fumimaro Takaku, International Medical Center of Japan 
Wayne Talton, Burroughs Wellcome 
Thomas Tar low, Chiron Corporation 
Paul Tolstoshev, Genetic Therapy, Inc 
Bruce Trapnell, Genetic Therapy, Inc 
Yuri Tsuzuki, Japan Broadcasting Corporation 
Dominick Vacante, Magenta Corporation 
Alan Venook, University of California, San Francisco 
Samuel Wadsworth, Genzyme Corporation 
Trish Waitschies, MD Anderson Cancer Center 
Kathryn Whartenby, Food and Drug Administration 
Lisa White, The Blue Sheet 
Sharon Williams, Life Technologies, Inc 
Savio Woo, Baylor College of Medicine 
Diane Zezza, Schering-Plough Corporation 
Shuyuan Zhang, Genetic Therapy, Inc 
Wei Zhang, MD Anderson Cancer Center 
Recombinant DNA Research, Volume 20 
[433] 
